Health Condition 1: M722- Plantar fascial fibromatosis
Conditions
Interventions
Intervention1: INJECTION OF TRIAMCINOLONE ACETONIDE: GROUP-A - Patients will receive Injection of 2ml of a suspension containing 20mg Triamcinolone acetonide(0.5 ml) and 2% solution of lignocaine (1.
Sponsors
SAMBHUNATH PANDIT HOSPITAL
DR KRISHNENDU ROY
Eligibility
Inclusion criteria
Inclusion criteria: 1) Clinically confirmed cases of chronic plantar fasciitis (duration more than 3 months) 2) Pes planus (mild to moderate) confirmed by AP & weight bearing lateral X-Ray of foot and ankle.
Exclusion criteria
Exclusion criteria: 1] Patients who are not willing or not in a sound mental state to give consent 2] Infection of foot and ankle for last 6 months 3] Tumours of foot and ankle 4] Recent fracture in last 6 months 5] Uncontrolled Diabetes Mellitus 6] Uncontrolled Hypertension 7] Patients with neurological deficits (motor, sensory) 8] Charcot atrophy 9] Foot deformity other than pesplanus 10] Patients with bleeding disorders 11] Patients with Psychiatric disorders 12] Patients with implanted pacemaker 13] Patients with skin disease 14] Deformity due to advanced leprosy, buergerâ??s disease 15] Known hypersensitivity to lignocaine 16] Rheumatoid arthritis 17] Gout 18] Pregnancy 19] Patients on anticoagulants 20] Previous steroid injections within past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)To assess any improvement in VAS score after corticosteroid injection 2)To assess any improvement in VAS score after UST Timepoint: 1) 0 WEEK 2) 4 WEEK 3) 8 WEEK 4) 12 WEEK | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To assess any improvement in FFI score. 2)To compare improvement in both the groups on the basis of those above parameters. Timepoint: 1) 0 WEEK 2) 4 WEEK 3) 8 WEEK 4) 12 WEEK | — |
Countries
India
Contacts
Public ContactDr Krishnendu Roy
Sambhunath Pandit Hospital, Annex-2 of IPGME&R & SSKMH.
Outcome results
None listed